Viewing

RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer. (Oncotarget, Mar 2018)

Madhura Kulkarni,1,4 Tuan Zea Tan,1 Nurfarhanah Bte Syed Sulaiman,1 John M. Lamar,2,5 Prashali Bansal,1,6 Jianzhou Cui,1 Yiting Qiao,1 and Yoshiaki Ito1,3. Author Information 1Cancer Science Institute, NUS, Singapore. 2Transnational Cancer Research Centre, Prashanti Cancer Care Mission and Indian Institute of Science Education and Research, Pune, India. 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of

Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia. (Leukemia, Mar 2018)

Thi Ngoc PC1, Tan SH1, Tan TK1, Chan MM1, Li Z2, Yeoh AEJ2,3, Tenen DG1,4,5, Sanda T6,7. Author Information 1 Cancer Science Institute of Singapore, National University of Singapore, Singapore 2 Centre for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore 3 VIVA-University Children's Cancer Centre, Khoo Teck

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia. (Nat Commun, Apr 2018)

Akihiko Numata1, Hui Si Kwok1, Akira Kawasaki1, Jia Li1, Qi-Ling Zhou1, Jon Kerry2, Touati Benoukraf1,Deepak Bararia1, Feng Li1, Erica Ballabio2, Marta Tapia2, Aniruddha J. Deshpande3, Robert S. Welner4,Ruud Delwel5, Henry Yang1, Thomas A. Milne2, Reshma Taneja6; Daniel G. Tenen1,7 Author Information: 1 Cancer Science Institute of Singapore, National University of Singapore 2 MRC Molecular Haematology